SUNDAY, JUNE 24, 2018

Johnson & Johnson

325 Paramount Dr
Raynham, MA 02767-5199

Johnson & Johnson News

Janssen Pharmaceutical leader says collaborations are critical in fight against HIV

HIV does not have one solution, which makes scientific collaborations vital for developing treatments and vaccines. Read More »

Researchers encourage innovation to decrease HIV infections in Africa

Johnson & Johnson recently launched the DREAMS Innovation Challenge to encourage researchers to think of innovative ways to decrease HIV infections throughout sub-Saharan Africa. Read More »

Janssen Pharmaceutical joins Human Vaccines Project

Crucell Holland BV, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has joined the Human Vaccines Project. Read More »

Johnson & Johnson launches clinical trial for Ebola vaccine in Sierra Leone

Johnson & Johnson recently announced that the company has launched its clinical trial for an Ebola vaccine regimen in Sierra Leone. Read More »